Hispanic Patients “Severely Under- Represented” in Liver Cancer Trials
Hispanic people have a disproportionately high incidence of liver cancer compared with other groups but are under-represented in Phase 3 trials for the disease.
Read MoreNov 2, 2023
Hispanic people have a disproportionately high incidence of liver cancer compared with other groups but are under-represented in Phase 3 trials for the disease.
Read MoreNov 1, 2023
The expansion of Medicaid positively impacted survival for patients undergoing surgical and multimodal treatment for stage 1-3 biliary tract cancer, according to findings published in the Journal of Surgical Oncology. Timothy...
Read MoreOct 31, 2023
Targeted treatment based on molecular characterization improves outcomes in biliary tract cancer, according to results published in Scientific Reports. Bernhard Doleschal, MD, PhD, and colleagues investigated the effectiveness...
Read MoreOct 29, 2023
Risk and reward are inherent to providing medical care. As such, it is essential that patients...
Read More